Nasdaq:US$18.76 (+0.25) | HKEX:HK$30.25 (-0.75) | AIM:£3.00 (+0.02)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 6 Apr 2013

AACR 2013: Preclinical disposition and pharmacokinetics of savolitinib, a novel selective cMet inhibitor